The company have substantially improved this progress of the new therapy for ATTR-CM, utilizing the compound. Initial trial information indicates potential outcomes for patients affected from the serious disease. The https://bridgebio514060.blogpostie.com/63378239/firm-improves-cardiac-amyloidosis-therapy-with-attruby